Cardiac Registry Software Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Cardiac Registry Software Market: By Types of Registry (Disease Registry, Heart Arrhythmia, Heart Valve Disease, Coronary Artery Disease, Heart Failure Others Health Service Registries, Product Registries, Medical Device Registries, Drug Registries) Type of Software (Standalone Software, Integrated Software) Pricing Model (Subscription Model, Ownership Model) Deployment Model (On-premises Model, Cloud-Based Model) Type of Database (Commercial Database, Public Database) Functionality (Population Health Management, Patient Care Management, Medical Research & Clinical Studies, Health Information Exchange, Point-of-Care, Product Outcome Evaluation) End User ( Government Organizations and Third-Party Administrators, Hospitals & Medical Practice, Private Payers, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The Cardiac Registry Software Market size is valued at USD 465.8 million in 2021 and is expected to grow at a significant CAGR of 8.8% during the forecast period from 2022 to 2028. The global market provides a detailed overview of the market and that can be segmented By types of registry, type of software, pricing model, deployment model, type of database, functionality, end user. By Types of Registry, the cardiac registry software market has been segmented into disease registry, health service registries, product registries, medical device registries, drug registries. The Disease Registry segment is likely to be the largest and fastest-growing segment in terms of types of registry. Based on type of software, the Cardiac Registry Software market is segmented into Standalone Software, Integrated Software.  Among these, the Standalone Software segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on the pricing model, the cardiac registry software market is segmented into Subscription Model, Ownership Model. Subscription Model are expected to dominate the market in the future. Based on deployment model, the market has been segmented into On-premises Model, Cloud-Based Model. On-premises Model segment expected to grow at the highest CAGR over the forecast years. Based on the type of database, the market has been segregated into Commercial Database, Public Database. The Commercial Database segment is to dominate other segments in the Cardiac Registry Software market. Based on the functionality, the market has been segregated into Population Health Management, Patient Care Management, Medical Research & Clinical Studies, Health Information Exchange, Point-of-Care, Product Outcome Evaluation. The Population Health Management segment is to dominate other segments in the Cardiac Registry Software market according to Precision Business Insights. Based on the type of end user, the market has been segregated into Government Organizations and Third-Party Administrators, Hospitals & Medical Practice, Private Payers, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers. The Government Organizations and Third-Party Administrators segment is to dominate other segments in the Cardiac Registry Software market according to Precision Business Insights.

Key Development:

In March 2021, ESO Solutions (US) entered into a partnership with Virginia EMS Systems (US) to deliver a statewide EMS data repository and statewide trauma registry for the collection and analysis of data to reveal key insights and trends.

Cardiac Registry Software Market

MARKET SUMMARY
-
8.8%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–  8.8%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market–  North America

Cardiac Registry Software Market

  • The global cardiac registry software market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The cardiac registry software market report gives historical, current, and future market sizes (US$ Mn) based on by types of registry, by Type of software, by pricing model, by deployment model, by type of database, by functionality, by end user and geography.
Key Players
  • IBM Corporation
  • IQVIA Holdings
  • OpenText Corporation
  • Optum
  • ARMUS Corporation
Cardiac Registry Software Market Drivers

The transition toward computerised registries which give users with an automated mechanism to save data and compile, organise, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery, is primarily responsible for the market’s rise.


Asia-Pacific Got Significant Share

Cardiac Registry Software Market

By region, the Asia Pacific market is expected to witness highest market share during the forecast period. Increasing incidence of cardiac diseases, rising awareness about the benefits of EHRs, improvements in healthcare systems, and the development of medical tourism in Asian countries are anticipated to propel the growth of market in the future.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The cardiac registry software market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cardiac Registry Software Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The cardiac registry software market is projected to expand at a CAGR of 8.8% during the forecast period.

The major players in the global Cardiac Registry Software market are IBM Corporation, IQVIA Holdings, OpenText Corporation, Optum, ARMUS Corporation, Premier, Inc., ArborMetrix, FIGmd, McKesson Corporation, Syneos Health, Dacima Software.

Asia Pacific is the fastest-growing region for cardiac registry software market


Report

Table Of Content

1. Executive Summary
2. Global Cardiac Registry Software Market Introduction
2.1. Global Cardiac Registry Software Market – Taxonomy
2.2. Global Cardiac Registry Software Market –Definitions
2.2.1. By Types of Registry
2.2.2. By Type of Software
2.2.3. By Pricing Model
2.2.4. By Deployment Model
2.2.5. By Type of Database
2.2.6. By Functionality
2.2.7. By End User
2.2.8. By Region
3. Global Cardiac Registry Software Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Registry Software Market Dynamic Factors – Impact Analysis
3.6. Global Cardiac Registry Software Market – Competition Landscape
4. Global Cardiac Registry Software Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cardiac Registry Software Market, By Types of Registry, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Disease Registry
5.1.1. Heart Arrhythmia
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Heart Valve Disease
5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Heart Failure
5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Coronary Artery Disease
5.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Others
5.1.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Health Service Registries
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Product Registries
5.3.1. Medical Device Registries
5.3.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Drug Registries
5.3.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
6. Global Cardiac Registry Software Market, By Type of Software, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Standalone Software
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Integrated Software
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Cardiac Registry Software Market, By Pricing Model, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.  Subscription Model
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2.  Ownership Model
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Cardiac Registry Software Market Forecast, By Deployment Model, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. On-premises Model
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Cloud Based Model
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Cardiac Registry Software Market Forecast, By Type of Database, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. Commercial Database
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Public Database
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
10. Global Cardiac Registry Software Market Forecast, By Functionality, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Population Health Management
10.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Patient Care Management
10.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3.  Medical Research & Clinical Studies
10.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4.  Health Information Exchange
10.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5.  Point-of-Care
10.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6.  Product Outcome Evaluation
10.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.6.3. Market Opportunity Analysis
11. Global Cardiac Registry Software Market Forecast, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Government Organizations and Third-Party Administrators
11.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
11.1.3. Market Opportunity Analysis
11.2. Hospitals & Medical Practices
11.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
11.2.3. Market Opportunity Analysis
11.3.  Private Payers
11.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
11.3.3. Market Opportunity Analysis
11.4.  Pharmaceutical, Biotechnology, and Medical Device Companies
11.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
11.4.3. Market Opportunity Analysis
11.5. Research Centers
11.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
11.5.3. Market Opportunity Analysis
12.  Global Cardiac Registry Software Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. North America
12.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
12.1.3. Market Opportunity Analysis
12.2. Europe
12.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
12.2.3. Market Opportunity Analysis
12.3. Asia-Pacific
12.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
12.3.3. Market Opportunity Analysis
12.4. Latin America
12.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
12.4.3. Market Opportunity Analysis
12.5. Middle East and Africa
12.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
12.5.3. Market Opportunity Analysis
12.6. Global Cardiac Registry Software Market – Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Region, 2022-2028
13. North America Cardiac Registry Software Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Types of Registry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Disease Registry
13.1.1.1. Heart Arrhythmia
13.1.1.2. Heart Valve Disease
13.1.1.3. Coronary Artery Disease
13.1.1.4. Heart Failure
13.1.1.5. Others
13.1.2. Health Service Registries
13.1.3. Product Registries
13.1.3.1. Medical Device Registries
13.1.3.2. Drug Registries
13.2. Type of Software Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Standalone Software
13.2.2. Integrated Software
13.3. Pricing Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Subscription Model
13.3.2. Ownership Model
13.4. Deployment Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. On-premises Model
13.4.2. Cloud-Based Model
13.5. Type of Database Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Commercial Database
13.5.2. Public Database
13.6. Functionality Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.6.1. Population Health Management
13.6.2. Patient Care Management
13.6.3. Medical Research & Clinical Studies
13.6.4. Health Information Exchange
13.6.5. Point-of-Care
13.6.6. Product Outcome Evaluation
13.7. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.7.1. Government Organizations and Third-Party Administrators
13.7.2. Hospitals & Medical Practices
13.7.3. Private Payers
13.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies
13.7.5. Research Centers
13.8. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.8.1. USA
13.8.2. Canada
13.9. North America Cardiac Registry Software Market – Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028
13.10. North America Cardiac Registry Software Market Dynamics – Trends
14. Europe Cardiac Registry Software Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Types of Registry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Disease Registry
14.1.1.1. Heart Arrhythmia
14.1.1.2. Heart Valve Disease
14.1.1.3. Coronary Artery Disease
14.1.1.4. Heart Failure
14.1.1.5. Others
14.1.2. Health Service Registries
14.1.3. Product Registries
14.1.3.1. Medical Device Registries
14.1.3.2. Drug Registries
14.2. Type of Software Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Standalone Software
14.2.2. Integrated Software
14.3. Pricing Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Subscription Model
14.3.2. Ownership Model
14.4. Deployment Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. On-premises Model
14.4.2. Cloud-Based Model
14.5. Type of Database Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Commercial Database
14.5.2. Public Database
14.6. Functionality Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.6.1. Population Health Management
14.6.2. Patient Care Management
14.6.3. Medical Research & Clinical Studies
14.6.4. Health Information Exchange
14.6.5. Point-of-Care
14.6.6. Product Outcome Evaluation
14.7. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.7.1. Government Organizations and Third-Party Administrators
14.7.2. Hospitals & Medical Practices
14.7.3. Private Payers
14.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies
14.7.5. Research Centers
14.8. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.8.1. Germany
14.8.2. UK
14.8.3. France
14.8.4. Spain
14.8.5. Italy
14.8.6. Russia
14.8.7. Rest of Europe
14.9. Europe Cardiac Registry Software Market – Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028
14.10. Europe Cardiac Registry Software Market Dynamics – Trends
15. Asia-Pacific Cardiac Registry Software Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
15.1. Types of Registry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1.  Disease Registry
15.1.1.1. Heart Arrhythmia
15.1.1.2. Heart Valve Disease
15.1.1.3. Coronary Artery Disease
15.1.1.4. Heart Failure
15.1.1.5. Others
15.1.2. Health Service Registries
15.1.3. Product Registries
15.1.3.1. Medical Device Registries
15.1.3.2. Drug Registries
15.2. Type of Software Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Standalone Software
15.2.2. Integrated Software
15.3. Pricing Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Subscription Model
15.3.2. Ownership Model
15.4. Deployment Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. On-premises Model
15.4.2. Cloud-Based Model
15.5. Type of Database Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Commercial Database
15.5.2. Public Database
15.6. Functionality Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.6.1. Population Health Management
15.6.2. Patient Care Management
15.6.3. Medical Research & Clinical Studies
15.6.4. Health Information Exchange
15.6.5. Point-of-Care
15.6.6. Product Outcome Evaluation
15.7. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.7.1. Government Organizations and Third-Party Administrators
15.7.2. Hospitals & Medical Practices
15.7.3. Private Payers
15.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies
15.7.5. Research Centers
15.8. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.8.1. China
15.8.2. India
15.8.3. Japan
15.8.4. ASEAN
15.8.5. Australia & New Zealand
15.8.6. Rest of Asia-Pacific
15.9. Asia-Pacific Cardiac Registry Software Market – Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028
15.10. Asia-Pacific Cardiac Registry Software Market Dynamics – Trends
16. Latin America Cardiac Registry Software Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
16.1. Types of Registry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
16.1.1.  Disease Registry
16.1.1.1. Heart Arrhythmia
16.1.1.2. Heart Valve Disease
16.1.1.3. Coronary Artery Disease
16.1.1.4. Heart Failure
16.1.1.5. Others
16.1.2. Health Service Registries
16.1.3. Product Registries
16.1.3.1. Medical Device Registries
16.1.3.2. Drug Registries
16.2. Type of Software Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
16.2.1. Standalone Software
16.2.2. Integrated Software
16.3. Pricing Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.3.1. Subscription Model
16.3.2. Ownership Model
16.4. Deployment Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.4.1. On-premises Model
16.4.2. Cloud-Based Model
16.5. Type of Database Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.5.1. Commercial Database
16.5.2. Public Database
16.6. Functionality Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.6.1. Population Health Management
16.6.2. Patient Care Management
16.6.3. Medical Research & Clinical Studies
16.6.4. Health Information Exchange
16.6.5. Point-of-Care
16.6.6. Product Outcome Evaluation
16.7. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
16.7.1. Government Organizations and Third-Party Administrators
16.7.2. Hospitals & Medical Practices
16.7.3. Private Payers
16.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies
16.7.5. Research Centers
16.8. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Latin America Cardiac Registry Software Market – Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028
16.10. Latin America Cardiac Registry Software Market Dynamics – Trends
17. Middle East and Africa Cardiac Registry Software Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
17.1. Types of Registry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
17.1.1.  Disease Registry
17.1.1.1. Heart Arrhythmia
17.1.1.2. Heart Valve Disease
17.1.1.3. Coronary Artery Disease
17.1.1.4. Heart Failure
17.1.1.5. Others
17.1.2. Health Service Registries
17.1.3. Product Registries
17.1.3.1. Medical Device Registries
17.1.3.2. Drug Registries
17.2. Type of Software Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
17.2.1. Standalone Software
17.2.2. Integrated Software
17.3. Pricing Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
17.3.1. Subscription Model
17.3.2. Ownership Model
17.4. Deployment Model Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
17.4.1. On-premises Model
17.4.2. Cloud-Based Model
17.5. Type of Database Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
17.5.1. Commercial Database
17.5.2. Public Database
17.6. Functionality Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
17.6.1. Population Health Management
17.6.2. Patient Care Management
17.6.3. Medical Research & Clinical Studies
17.6.4. Health Information Exchange
17.6.5. Point-of-Care
17.6.6. Product Outcome Evaluation
17.7. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
17.7.1. Government Organizations and Third-Party Administrators
17.7.2. Hospitals & Medical Practices
17.7.3. Private Payers
17.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies
17.7.5. Research Centers
17.8. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
17.8.1. Gulf Cooperation Council (GCC) Countries
17.8.2. South Africa
17.8.3. Rest of MEA
17.9. MEA Cardiac Registry Software Market – Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028
17.10. MEA Cardiac Registry Software Market Dynamics – Trends
18. Competition Landscape 
18.1. Strategic Dashboard of Top Market Players
18.2. Company Profiles (Introduction, Financial Analysis, Key Product, Key Developments, Strategies, and SWOT Analysis)
18.2.1. IBM Corporation
18.2.2. IQVIA Holdings
18.2.3. OpenText Corporation
18.2.4. Optum
18.2.5. ARMUS Corporation
18.2.6. Premier, Inc.
18.2.7. ArborMetrix
18.2.8. FIGmd
18.2.9. McKesson Corporation
18.2.10. Syneos Health
18.2.11. Dacima Software
19. Research Methodology
20. Key Assumptions and Acronyms

Report

Company Profile

  • IBM Corporation
  • IQVIA Holdings
  • OpenText Corporation
  • Optum
  • ARMUS Corporation
  • Premier, Inc.
  • ArborMetrix
  • FIGmd
  • McKesson Corporation
  • Syneos Health
  • Dacima Software

Description

The Cardiac Registry Software Market size is valued at USD 465.8 million in 2021 and is expected to grow at a significant CAGR of 8.8% during the forecast period from 2022 to 2028. The global market provides a detailed overview of the market and that can be segmented By types of registry, type of software, pricing model, deployment model, type of database, functionality, end user. By Types of Registry, the cardiac registry software market has been segmented into disease registry, health service registries, product registries, medical device registries, drug registries. The Disease Registry segment is likely to be the largest and fastest-growing segment in terms of types of registry. Based on type of software, the Cardiac Registry Software market is segmented into Standalone Software, Integrated Software.  Among these, the Standalone Software segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on the pricing model, the cardiac registry software market is segmented into Subscription Model, Ownership Model. Subscription Model are expected to dominate the market in the future. Based on deployment model, the market has been segmented into On-premises Model, Cloud-Based Model. On-premises Model segment expected to grow at the highest CAGR over the forecast years. Based on the type of database, the market has been segregated into Commercial Database, Public Database. The Commercial Database segment is to dominate other segments in the Cardiac Registry Software market. Based on the functionality, the market has been segregated into Population Health Management, Patient Care Management, Medical Research & Clinical Studies, Health Information Exchange, Point-of-Care, Product Outcome Evaluation. The Population Health Management segment is to dominate other segments in the Cardiac Registry Software market according to Precision Business Insights. Based on the type of end user, the market has been segregated into Government Organizations and Third-Party Administrators, Hospitals & Medical Practice, Private Payers, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers. The Government Organizations and Third-Party Administrators segment is to dominate other segments in the Cardiac Registry Software market according to Precision Business Insights.

Key Development:

In March 2021, ESO Solutions (US) entered into a partnership with Virginia EMS Systems (US) to deliver a statewide EMS data repository and statewide trauma registry for the collection and analysis of data to reveal key insights and trends.

Reviews

There are no reviews yet.

Be the first to review “Cardiac Registry Software Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX